Selection of single domain binding proteins by covalent DNA display

被引:34
作者
Bertschinger, Julian [1 ]
Grabulovski, Dragan [1 ]
Neri, Dario [1 ]
机构
[1] ETH Honggerberg, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland
关键词
covalent; DNA display; FynSH3; scaffold; selection;
D O I
10.1093/protein/gzl055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Selection technologies such as phage and ribosome display, which provide a physical linkage between genetic information and encoded polypeptide, are important tools for the engineering of proteins for diagnostic and therapeutic applications. We have recently described a selection strategy called covalent DNA display, in which individual proteins are covalently linked to the cognate encoding DNA template in separate droplets of a water-in-oil emulsion. We here report on the optimization of several experimental steps in covalent DNA display technology, such as the elution conditions and the PCR strategy used for the amplification of selected DNA templates. A PCR assembly strategy was developed, which allows the amplification of the DNA templates over repeated rounds of selection. In addition, we could demonstrate that similar to 50% of the DNA templates form a covalent adduct with the corresponding proteins in the compartments of a water-in-oil emulsion. In model selection experiments, differences in recovery efficiency < 100 000 per round of selection could be observed when comparing a specific binding polypeptide with a binder of irrelevant specificity. Furthermore, the optimized protocol was successfully applied for the selection of single domain proteins, capable of specific binding to mouse serum albumin (MSA). A mutant derived from the SH3 domain of the Fyn kinase, with millimolar affinity to MSA, was affinity matured using covalent DNA display and yielded several MSA binding FynSH3 variants with dissociation constants in the 100 nM range.
引用
收藏
页码:57 / 68
页数:12
相关论文
共 32 条
[1]   Covalent DNA display as a novel tool for directed evolution of proteins in vitro [J].
Bertschinger, J ;
Neri, D .
PROTEIN ENGINEERING DESIGN & SELECTION, 2004, 17 (09) :699-707
[2]   Engineering novel binding proteins from nonimmunoglobulin domains [J].
Binz, HK ;
Amstutz, P ;
Plückthun, A .
NATURE BIOTECHNOLOGY, 2005, 23 (10) :1257-1268
[3]   DIRECT IDENTIFICATION OF THE ACTIVE-SITE NUCLEOPHILE IN A DNA (CYTOSINE-5)-METHYLTRANSFERASE [J].
CHEN, L ;
MACMILLAN, AM ;
CHANG, W ;
EZAZNIKPAY, K ;
LANE, WS ;
VERDINE, GL .
BIOCHEMISTRY, 1991, 30 (46) :11018-11025
[4]   MUTATIONAL SEPARATION OF DNA-BINDING FROM CATALYSIS IN A DNA CYTOSINE METHYLTRANSFERASE [J].
CHEN, L ;
MACMILLAN, AM ;
VERDINE, GL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (12) :5318-5319
[5]   Albumin binding as a general strategy for improving the pharmacokinetics of proteins [J].
Dennis, MS ;
Zhang, M ;
Meng, YG ;
Kadkhodayan, M ;
Kirchhofer, D ;
Combs, D ;
Damico, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) :35035-35043
[6]   STABLE: protein-DNA fusion system for screening of combinatorial protein libraries in vitro [J].
Doi, N ;
Yanagawa, H .
FEBS LETTERS, 1999, 457 (02) :227-230
[7]   Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library [J].
Feldhaus, MJ ;
Siegel, RW ;
Opresko, LK ;
Coleman, JR ;
Feldhaus, JMW ;
Yeung, YA ;
Cochran, JR ;
Heinzelman, P ;
Colby, D ;
Swers, J ;
Graff, C ;
Wiley, HS ;
Wittrup, KD .
NATURE BIOTECHNOLOGY, 2003, 21 (02) :163-170
[8]  
GRABULOVSKI D, 2006, IN PRESS J BIOR CHEM
[9]   Directed evolution of an extremely fast phosphotriesterase by in vitro compartmentalization [J].
Griffiths, AD ;
Tawfik, DS .
EMBO JOURNAL, 2003, 22 (01) :24-35
[10]   Artificial, non-antibody binding proteins for pharmaceutical and industrial applications [J].
Hey, T ;
Fiedler, E ;
Rudolph, R ;
Fiedler, M .
TRENDS IN BIOTECHNOLOGY, 2005, 23 (10) :514-522